Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-30

Clinical Trial Update: Neurocutaneous Melanocytosis Registry

View source ↗

Summary

This clinical trial update shows that the Neurocutaneous Melanocytosis Registry is currently recruiting participants at Memorial Sloan Kettering Cancer Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Cutaneous Melanocytic Neoplasm, Large Cutaneous Melanocytic Nevi | Status: RECRUITING